Thrombotic Complications in Inflammatory Bowel Disease

The risk of thrombotic complications is known to be 3 times higher in patients with inflammatory bowel disease (IBD) than in healthy individuals, with the relative risk being 15 times higher during the periods of relapses. Aim. To study and generalize literature data available on the prevention and...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Borota, A. A. Borota, E. V. Onishchenko
Format: Article
Language:Russian
Published: Gastro LLC 2019-05-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/351
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860117757493248
author A. V. Borota
A. A. Borota
E. V. Onishchenko
author_facet A. V. Borota
A. A. Borota
E. V. Onishchenko
author_sort A. V. Borota
collection DOAJ
description The risk of thrombotic complications is known to be 3 times higher in patients with inflammatory bowel disease (IBD) than in healthy individuals, with the relative risk being 15 times higher during the periods of relapses. Aim. To study and generalize literature data available on the prevention and treatment of IBD thrombotic complications.Key findings. In the сonditions under study, the presence of chronic inflammation and increased bleeding of the intestinal wall is shown to activate the coagulation system, impair the fibrinolysis system and reduce the activity of natural anticoagulation mechanisms. The concentration of fibrinogen — a protein of the acute inflammation phase — increases significantly. This results in an imbalance of the blood coagulation system with a tendency to hypercoagulation, which significantly increases the risk of thrombotic complications and the disseminated intravascular coagulation syndrome. In turn, the activation of the coagulation cascade may trigger the inflammatory response, which eventually leads to the formation of a vicious circle between chronic inflammation and thrombosis. The pathogenesis of thrombosis in inflammatory colon diseases is a multifactor process, which remains to be understood.Conclusion.The management of patients with IBD in combination with thromboembolic complications requires an individual multidisciplinary approach. Taking into account the pathogenetic factors, the following options are possible in the prevention and treatment of thrombotic complications in IBD: strengthening the basic therapy of the primary disease; administration of prophylactic doses of anticoagulants under dynamic continuous laboratory control in the acute period using the methods of conservative therapy of thrombotic complications (elastic compression of the lower extremities) in the period of exacerbation of the primary disease.
format Article
id doaj-art-32390be9adbf4e6fa09afdf52778a7f6
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2019-05-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-32390be9adbf4e6fa09afdf52778a7f62025-02-10T16:14:35ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732019-05-01292232610.22416/1382-4376-2019-29-2-23-26300Thrombotic Complications in Inflammatory Bowel DiseaseA. V. Borota0A. A. Borota1E. V. Onishchenko2M. Gorky Donetsk National Medical UniversityM. Gorky Donetsk National Medical UniversityM. Gorky Donetsk National Medical UniversityThe risk of thrombotic complications is known to be 3 times higher in patients with inflammatory bowel disease (IBD) than in healthy individuals, with the relative risk being 15 times higher during the periods of relapses. Aim. To study and generalize literature data available on the prevention and treatment of IBD thrombotic complications.Key findings. In the сonditions under study, the presence of chronic inflammation and increased bleeding of the intestinal wall is shown to activate the coagulation system, impair the fibrinolysis system and reduce the activity of natural anticoagulation mechanisms. The concentration of fibrinogen — a protein of the acute inflammation phase — increases significantly. This results in an imbalance of the blood coagulation system with a tendency to hypercoagulation, which significantly increases the risk of thrombotic complications and the disseminated intravascular coagulation syndrome. In turn, the activation of the coagulation cascade may trigger the inflammatory response, which eventually leads to the formation of a vicious circle between chronic inflammation and thrombosis. The pathogenesis of thrombosis in inflammatory colon diseases is a multifactor process, which remains to be understood.Conclusion.The management of patients with IBD in combination with thromboembolic complications requires an individual multidisciplinary approach. Taking into account the pathogenetic factors, the following options are possible in the prevention and treatment of thrombotic complications in IBD: strengthening the basic therapy of the primary disease; administration of prophylactic doses of anticoagulants under dynamic continuous laboratory control in the acute period using the methods of conservative therapy of thrombotic complications (elastic compression of the lower extremities) in the period of exacerbation of the primary disease.https://www.gastro-j.ru/jour/article/view/351ulcerative colitiscrohn’s diseasethrombosis
spellingShingle A. V. Borota
A. A. Borota
E. V. Onishchenko
Thrombotic Complications in Inflammatory Bowel Disease
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
ulcerative colitis
crohn’s disease
thrombosis
title Thrombotic Complications in Inflammatory Bowel Disease
title_full Thrombotic Complications in Inflammatory Bowel Disease
title_fullStr Thrombotic Complications in Inflammatory Bowel Disease
title_full_unstemmed Thrombotic Complications in Inflammatory Bowel Disease
title_short Thrombotic Complications in Inflammatory Bowel Disease
title_sort thrombotic complications in inflammatory bowel disease
topic ulcerative colitis
crohn’s disease
thrombosis
url https://www.gastro-j.ru/jour/article/view/351
work_keys_str_mv AT avborota thromboticcomplicationsininflammatoryboweldisease
AT aaborota thromboticcomplicationsininflammatoryboweldisease
AT evonishchenko thromboticcomplicationsininflammatoryboweldisease